A Clinical Study to Evaluate the Safety and Tolerability of JS107 in Advanced Pancreatic Cancer
Clinical trial NCT05657418 · TERMINATED
Trial details
- NCT number
- NCT05657418
- Sponsor
- Shanghai Junshi Bioscience Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-29
- Primary completion
- 2025-01-04
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.